Chitosan-based materials show considerable potential for fruit preservation but are limited by poor solubility and relatively weak antibacterial activity. In this study, we developed a zwitterionic betaine-modified chitosan (BM-CS) with tunable degrees of substitution using a low-temperature homogeneous alkali/urea system. The resulting BM-CS exhibited marked enhanced water solubility, film-forming ability, and broad-spectrum antibacterial activity, while maintaining good biocompatibility with both HMEC-1 and HIEC-6 cells (>90% viability). Compared with native chitosan, BM-CS films displayed reduced crystallinity, improved thermal stability, and increased tensile strength (up to 77.78 MPa vs. 57.79 MPa for unmodified chitosan). The films also demonstrated rapid biodegradability, reaching 93.4% degradation within 7 days in soil, as well as excellent storage stability, retaining >98% of their antibacterial activity after 50 days. When applied as edible coatings, BM-CS effectively reduced water loss, ethylene production, and nutrient consumption in grapes, cherry tomatoes, and strawberries, while maintaining total phenolic content and VC retention. Notably, the high-substitution BM-CS achieved weight losses of only 18.3% and 16.1% after 18 days, significantly lower than the control (>45%), and 2.41% after 7 days for strawberries (control >18%). These findings indicate that zwitterionic modification is an effective strategy to enhance the functional performance of chitosan, highlighting BM-CS as a promising sustainable material for postharvest fruit preservation.

The trifluoroacetyl group is a widely used and easily removable amino-protecting group, making it an ideal choice for protecting the amino groups of chitosan. However, current methods for trifluoroacetylation of chitosan suffer from low reaction efficiency and limited modification degrees, posing a persistent challenge for achieving complete N-trifluoroacetylation. In this study, a simple and efficient method for preparing amino-protected chitosan, specifically N-trifluoroacetyl chitosan, is presented. The process is carried out in a homogeneous solution at room temperature, without the need for stringent anhydrous or oxygen-free conditions, and involves a brief reaction time. N-trifluoroacetyl chitosan exhibits good solubility in organic solvents, enabling homogeneous reactions with reagents such as enol ethers or t-butyldimethylchlorosilane. Furthermore, the protecting group can be easily removed under mild conditions. This method for amino group protection in chitosan offers a convenient approach for subsequent modifications.

Hydrogel wound dressings have shown promising potential for treating diabetic wounds, but their efficacy is limited by the complex wound microenvironment and the lack of integrated treatment strategies. In this study, a series of multifunctional hydrogel adhesives with anti-inflammatory, antibacterial, and angiogenesis-promoting properties was synthesized using free radical polymerization. The raw materials included methacrylated hyaluronic acid (HAMA), 3-(bis(pyridin-2-ylmethyl)amino)propyl methacrylate (DPAMA), and N-[tris(hydroxymethyl)methyl]acrylamide (THMA). Cu2+ ions were incorporated into the hydrogels through their strong affinity for dipicolylamine and carboxylic acid groups. Adhesion strength of the hydrogel ranged from 8 to 14 kPa, and tensile strength was 14.9 kPa. The inhibition zones against Escherichia coli and Staphylococcus aureus were 16.16 mm and 14.5 mm, respectively. ELISA results showed that the HTDC2 hydrogel (containing 3 mg/mL Cu2+) significantly reduced TNF-α and IL-1β expression. The HTDC2 hydrogel significantly promoted full-thickness skin wound healing in diabetic mice, achieving over 85 % closure by day 14. Western blot data showed that TNF-α and IL-1β protein levels in HTDC2 group decreased 3.5-fold on day 10 compared with control. Angiogenesis, immunofluorescence, and immunohistochemistry results confirmed that HTDC2 promoted angiogenesis and reduced pro-inflammatory factor expression. In summary, the proposed supramolecular polymer/hyaluronic acid hydrogel is promising as a diabetic wound dressing.

Here, we developed and demonstrated a novel integrative system-Silica Nanorods (SNA) substrate cell capture combined with Supramolecular Nanoparticle (SMNP) delivery mediated CBE base editing (SNA & sdot;SMNP & sdot;CBE)- achieving the synchronization of CD34+HSPCs cell capture and gene editing for beta-hemoglobinopathies. First, in vitro study shows it enables efficient and precise modification of BCL11A promoter in CD34+HSPCs, yielding the highly editing efficiency of 50.4 %, thus making an alternative strategy to conventional immunomagnetic cell separation and electroporation transfection system mediated CBE editing (IMS & sdot;EP & sdot;CBE). Then, we transplanted the edited human CD34+HSPCs into severe combined immunodeficiency (SCID) mice by using intraosseous injection strategy. When compared with conventional IMS & sdot;EP & sdot;CBE methods, our results showed that significantly higher human HBG expression in the bone marrow and peripheral blood of recipient mice, and long-term engraftment, evidenced from similar gene expression profiles to na & iuml;ve CD34+HSPCs at 14 weeks. Conclusively, our integrative system-SNA & sdot;SMNP & sdot;CBE & sdot;intraosseous injection-offers an appealing novel way for the unique potential of gene therapy in the clinic application for beta-hemoglobinopathies patients.

Diabetic patients often struggle with wound healing and are at higher risk of infections, necessitating the development of a stretchable, adhesive hydrogel dressing with antibacterial and angiogenesis-promoting properties. In this study, we synthesized a series of adhesive, antibacterial and anti-inflammatory hydrogels using free radical polymerization with materials including methacrylated hyaluronic acid (HAMA), N-[tris(hydroxymethyl) methyl]acrylamide (THMA), and 3-(bis(pyridin-2-ylmethyl)amino)propyl methacrylate (DPAMA). By leveraging the strong affinity of zinc(II)-dipicolylamine coordination complexes for the phosphorylated groups in dexamethasone sodium phosphate (DMSP), Zn2+ and DMSP were successfully incorporated into the hydrogel. The results demonstrated that the hydrogels possessed excellent adhesiveness and mechanical properties, enabling them to adhere closely to the skin while remaining easily removable without causing trauma. Antibacterial tests demonstrated significant inhibitory effects against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), attributed to the slow release of Zn2+, which effectively suppressed bacterial growth. Additionally, the slow release of DMSP provided strong anti-inflammatory effects. The DHTDZ2 hydrogel, containing 1.5 mg/mL Zn2+ and 4 mg/mL DMSP, significantly accelerated the healing of full-thickness skin wounds. In vitro angiogenesis, immunofluorescence, and immuno-histochemical results further confirmed that the DHTDZ2 hydrogel promoted angiogenesis and reduced the expression of pro-inflammatory factors. In summary, the hydrogel is an effective wound healing dressing that can reduce wound infections and inflammation.

Osteoarthritis (OA) is a chronic musculoskeletal disorder, characterized by the chronic and progressive degenerative illness of articular cartilage that leads to tenacious joint pain and inflammation as well as functional disability, impairing the life quality in elderly people. Unfortunately, there is no regenerative therapy for treating osteoarthritis. Curcumin (diferuloylmethane), a hydrophobic polyphenol compound isolated from curcuma longa rhizome, has been broadly employed as a safe supplement traditionally. Despite great beneficial impacts, achieving the desired pharmacological effects of curcumin has shown limitations because of its low systemic bioavailability. It has been found that biological activities and bioavailability of curcumin could be efficiently enhanced using nanoscale drug carriers. The current literature review aimed to discuss nanoscale delivery systems that have been constructed to improve the bioavailability and therapeutic efficacy of curcumin for treating osteoarthritis. In brief, various delivery systems composed of polymer, metal, or emulsion nanocarriers have been manufactured to improve the bioavailability and therapeutic efficacy of curcumin in the treatment of osteoarthritis. Intra-articular injection of curcumin nanoparticles could induce chondrogenesis, inhibit degradation of articular cartilage, and reverse abnormalities in joint structure and smooth surface of articular cartilage in knee osteoarthritis, thus preventing osteoarthritis development, mechanistically, through anti-inflammatory and anti-oxidative activities of curcumin. In conclusion, nano-formulations of curcumin have been found to enhance the therapeutic efficacy of curcumin for treating osteoarthritis and introduce a promising therapeutic alternative to current therapies, however, future clinical investigations are warranted to approve their application in humans.

Chondrocyte senescence and reduced lubrication play pivotal roles in the pathogenesis of age-related osteoarthritis (OA). In the present study, highly lubricated and drug-loaded hydrogel microspheres are designed and fabricated through the radical polymerization of sulfobetaine (SB)-modified hyaluronic acid methacrylate using microfluidic technology. The copolymer contains a large number of SB and carboxyl groups that can provide a high degree of lubrication through hydration and form electrostatic loading interactions with metformin (Met@SBHA), producing a high drug load for anti-chondrocyte senescence. Mechanical, tribological, and drug release analyses demonstrated enhanced lubricative properties and prolonged drug dissemination of the Met@SBHA microspheres. RNA sequencing (RNA-seq) analysis, network pharmacology, and in vitro assays revealed the extraordinary capacity of Met@SBHA to combat chondrocyte senescence. Additionally, inducible nitric oxide synthase (iNOS) has been identified as a promising protein modulated by Met in senescent chondrocytes, thereby exerting a significant influence on the iNOS/ONOO-/P53 pathway. Notably, the intra-articular administration of Met@SBHA in aged mice ameliorated cartilage senescence and OA pathogenesis. Based on the findings of this study, Met@SBHA emerges as an innovative and promising strategy in tackling age-related OA serving the dual function of enhancing joint lubrication and mitigating cartilage senescence.

Background: The Juan-Bi decoction (JBD) is a classic traditional Chinese medicines (TCMs) prescription for the treatment of rheumatoid arthritis (RA). However, the active compounds of the JBD in RA treatment remain unclear.Aim: The aim of this study is to screen effective compounds in the JBD for RA treatment using systems pharmacology and experimental approaches.Method: Botanical drugs and compounds in the JBD were acquired from multiple public TCM databases. All compounds were initially screened using absorption, distribution, metabolism, excretion, and toxicity (ADMET) and physicochemical properties, and then a target prediction was performed. RA pathological genes were acquired from the DisGeNet database. Potential active compounds were screened by constructing a compound–target–pathogenic gene (C-T-P) network and calculating the cumulative interaction intensity of the compounds on pathogenic genes. The effectiveness of the compounds was verified using lipopolysaccharide (LPS)-induced RAW.264.7 cells and collagen-induced arthritis (CIA) mouse models.Results: We screened 15 potentially active compounds in the JBD for RA treatment. These compounds primarily act on multiple metabolic pathways, immune pathways, and signaling transduction pathways. Furthermore, in vivo and in vitro experiments showed that bornyl acetate (BAC) alleviated joint damage, and inflammatory cells infiltrated and facilitated a smooth cartilage surface via the suppression of the steroid hormone biosynthesis.Conclusion: We screened potential compounds in the JBD for the treatment of RA using systems pharmacology approaches. In particular, BAC had an anti-rheumatic effect, and future studies are required to elucidate the underlying mechanisms.

In clinical terms, chronic pain is the most prevalent sequela resulting from COVID-19, which is induced by the novel coronavirus (SARS-CoV-2), while type 2 diabetes mellitus (T2D) is the most common comorbidity. This triangular relationship can be attributed to the dysfunction of the insulin receptor signaling system (IRSS) in both central and peripheral systems. Patients with T2D are essentially more susceptible to SARS-CoV-2 infection due to the widespread expression of angiotensin converting enzyme 2 (ACE2) in their pancreatic beta cells, which serves as the cellular port for the SARS-CoV-2 to infect and enter the cell. This infection can exacerbate chronic pain and insulin resistance for various reasons. Peripherally, once infected, the virus can cause damage to peripheral nerves and pancreatic β-cells, further exacerbating pain and glucose metabolism conditions. Additionally, in the central nervous system, dysfunctional IRSS is closely linked to chronic pain. Over the past few years of the COVID-19 pandemic, an increasing body of evidence suggests that insulin and other medications currently used in clinical practice for hyperglycemia control may not be safe for treating these patients. Therefore, we need a proper approach for the treatment of chronic pain in long COVID patients, especially patients with T2D. This review presents evidence that transcutaneous auricular vagal nerve stimulation (taVNS) may provide a viable treatment option for chronic pain and metabolic dysfunction by improving the function of IRSS in both the central nervous system and peripheral tissues.

Treatment of acute osteomyelitis (OM) poses a significant challenge because of the difficulty in removing bacteria and the aberrant innate immune responses at the infection site. Topical ozone therapy has demonstrated favorable outcomes in treating OM, but its high reactivity and short half-life severely limit its clinical application. To address this issue, a suitable ozone delivery system that can promote the therapeutic effects of topical ozone therapy in OM is needed. In this study, we developed ozone-loaded fluorinated hyaluronic acid nanoparticles embedded in a thermoresponsive hydroxypropyl chitin (HPCH) hydrogel (Ozone@Gel) for treating acute OM. The ozone-delivering nanocomposite hydrogel could release ozone continuously and stably at the injection site for over 15 days. The ozone loaded in this ozone-delivering nanocomposite hydrogel was about 100 mg/L. In vitro antibacterial experiments demonstrated that the Ozone@Gel effectively attenuated Staphylococcus aureus proliferation and reduced biofilm formation by inhibiting the expression of bacterial polysaccharide-related genes (agr, atlE, aap, icaA, and icaBC). Further, animal experiments showed that Ozone@Gel effectively reduced bacterial load at the site of infection by enhancing neutrophil antimicrobial activity, thereby alleviating the progression of acute OM. Thus, this novel therapeutic strategy based on topical ozone therapy is a promising and feasible intervention for treating acute S. aureus OM.

Among cyanobacterium, Arthrospira platensis (A. platensis) is a rich source of diverse bioactive compounds due to its high protein, essential amino acid, vitamin, and mineral content. A. platensis is one of the most abundant sources of protein (50–70%). In the food industry, A. platensis is being used as an ingredient for the development of food flavor, taste, and nutritional composition. Several in vitro and in vivo studies have revealed the potential use of A. platensis in the prevention and treatment of various metabolic diseases. Recently, extensive research has focused on the production and bioactivity of the A. platensis-derived bioactive peptides. A series of steps were used for the production of bioactive peptides including hydrolysis, ultrafiltration, and chromatographic techniques, coupled with an advanced detector. A. platensis peptides showed health benefits such as anti-hypertension, anti-diabetes, anti-microbial, antioxidant, anti-obesity, and anti-cancer activities. This review aims to present the main nutritional composition of A. platensis, the processes of purification, and the identification of bioactive peptides, and the potential health benefits such as antihypertensive, antidiabetic, anti-cancer, anti-obesity, antioxidant, and anti-microbial activities associated with the consumption of A. platensis-derived peptides are discussed. The originality of this review over the old review is that our review comprehensively studies the macro- and micronutrient composition and listed bioactive peptides to date, which can play an important role in the treatment of various diseases. Moreover, this review provides information related the research gaps of the various technologies that should be used for the development of the peptide as a pharmaceutical and functional food.

Chitosan-based hydrogels crosslinked through covalent bonds have been extensively researched for their remarkable wound healing properties. However, their practical application has been limited due to the complexity of the preparation process and weak tissue-adhesive strength. In this study, we present a straightforward method for producing tissue-adhesive carboxymethyl chitosan hydrogels consisting of a single component, without the need for an initiator, catalyst, or external crosslinking agent. We synthesized o-nitrobenzyl alcohol-conjugated carboxymethyl chitosan and utilized 365 nm LED light irradiation to self-crosslink the hydrogels through photo-triggered o-nitrobenzyl alcohol and primary amine cyclization. The resulting o-nitrosobenzaldehyde groups not only covalently crosslinked carboxymethyl chitosan chains but also formed robust covalent bonds with the amino groups from the tissue surface, resulting in enhanced adhesion. Furthermore, the hydrogels demonstrated favorable biocompatibility. In vivo studies using a mice full-thickness defect model demonstrated that the hydrogel significantly accelerated wound healing, indicating their potential as a wound repair dressing.

BACKGROUND:Human cytomegalovirus (HCMV) is a herpesvirus that can infect various cell types and modulate host gene expression and immune response. It has been associated with the pathogenesis of various cancers, but its molecular mechanisms remain elusive. METHODS:We comprehensively analyzed the expression of HCMV pathway genes across 26 cancer types using the Cancer Genome Atlas (TCGA) and The Genotype-Tissue Expression (GTEx) databases. We also used bioinformatics tools to study immune invasion and tumor microenvironment in pan-cancer. Cox regression and machine learning were used to analyze prognostic genes and their relationship with drug sensitivity. RESULTS:We found that HCMV pathway genes are widely expressed in various cancers. Immune infiltration and the tumor microenvironment revealed that HCMV is involved in complex immune processes. We obtained prognostic genes for 25 cancers and significantly found 23 key genes in the HCMV pathway, which are significantly enriched in cellular chemotaxis and synaptic function and may be involved in disease progression. Notably, CaM family genes were up-regulated and AC family genes were down-regulated in most tumors. These hub genes correlate with sensitivity or resistance to various drugs, suggesting their potential as therapeutic targets. CONCLUSIONS:Our study has revealed the role of the HCMV pathway in various cancers and provided insights into its molecular mechanism and therapeutic significance. It is worth noting that the key genes of the HCMV pathway may open up new doors for cancer prevention and treatment.

Bone protein is a significant secondary product of the meat industry, comprising a substantial quantity of protein. These proteins could be broken down through enzymatic hydrolysis to generate antioxidant peptides. This study aimed to produce antioxidant peptides from bovine bone extract by enzymatic hydrolysis utilizing Flavourzyme and Protamex by optimizing enzyme amounts and time using the Box–Behnken design. The final optimized conditions obtained through the model were as follows: The amount of Flavourzyme was 1,100 U, the amount of Protamex was 2,814 U, and the time was 3.77 (h). Bovine bone extract hydrolysate (BBEH) was purified stepwise using ultrafiltration membranes with molecular cutoffs of 5, 3, and 1 kDa. To assess the antioxidant capacity of the fractions, several methods were used, including radical scavenging activity “1,1-diphenyl-2-picrylhydrazyl (DPPH),” “2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS),” metal chelating activity (MCA), reducing power (RP), and thiobarbituric acid assay (TBA). The results indicated that the ultrafiltration fraction with a molecular weight of less than 1 kDa showed significant antioxidant activity, with 48, 42, and 50% inhibition rates for DPPH, ABTS, and metal chelating, respectively. Using size exclusion chromatography, the fraction with a molecular weight less than 1 kDa was further separated into five sub-fractions: Frac-I, Frac-II, Frac-III, Frac-IV, and Frac-V. Sub-Frac-III, which exhibits significant DPPH radical scavenging activity (55%) and a reducing power of 0.8 at 700 nm, was separated into six sub-sub-fractions using reversed-phase HPLC (RP-HPLC) based on molecular weight and hydrophobicity. The sub-sub-fraction with the highest value for DPPH radical scavenging activity was sub-Fra-III-6, which exhibited approximately 69.45% activity. The sub-Fra-III-6 was analyzed using LC–MS/MS, which identified two specific peptides: Ala-Pro-Phe with a mass of 333.12 Da and Asp-His-Val with a mass of 369.14 Da. These two peptides are likely the primary peptides that might have a crucial role in antioxidant capacity. It can be concluded that BBEH is a valuable source of natural antioxidants and has the potential to serve as a viable resource in the cultured meat industry.

4-1BB agonists for cancer immunotherapy have shown good preliminary efficacy in clinical trials, but several of the first-generation 4-1BB agonistic antibodies entering the clinic have failed due to safety issues. Selenium nanoparticles (SeNPs) exhibit anti-inflammatory, anti-tumor, antioxidant, and immune-modulating properties. In addition, they have been shown to have detoxifying effects and prevent oxidative liver damage. In this study, we used an anti-4-1BB antibody in combination with SeNPs to evaluate the anti-lung cancer effects in in vitro and in vivo experiments and explore the underlying mechanisms by pathological analyses, quantitative PCR, and enzyme-linked immunoassay. We found that 5 μmol·L–1 anti-4-1BB antibody combined with 1 μmol·L–1 SeNPs increased the expression of IFN-γ and promoted the killing effects of peripheral blood mononuclear cells on Lewis lung carcinoma cells, with a lethality rate up to 56.88 %. Experiments in tumor-bearing mice showed that the tumor inhibition rate was 58.61 % after treatment with 3.5 mg/kg anti-4-1BB antibody combined with 0.25 mg/kg SeNPs, and the liver function index returned to normal. When the combined treatment was compared with the antibody treatment alone, detection of immune relevant factors demonstrated that the expression of FOXP3, IL-2, IL-12, and TNF-α in the spleen was downregulated, whereas the expression of IFN-γ in the spleen, serum, and tumor was upregulated, accompanied by increased Fas ligand expression in the tumor tissues. Based on these findings, we get the conclusion that anti-4-1BB antibody combined with SeNPs may alleviate the immunosuppression of regulatory T cells, promote the immune cell proliferation and metastasis to synergistically kill tumor cells. This combination also reduces the inflammatory damage to normal tissues and slows overstimulation of the splenic immune response.

Highly substituted perfluoroacylated chitosan can alter the physicochemical properties of chitosan; however, the currently synthesized perfluoroacylated chitosan has a low degree of substitution. In this study, we present a simple method for the homogeneous preparation of highly substituted N-perfluoroacylated chitosan, conducted at room temperature without requiring strict anhydrous or oxygen-free conditions. Various perfluorocarbon chains were successfully attached to chitosan through a reaction between perfluorinated acid esters and amines, catalyzed by DBU. The synthesized N-perfluoroacylated chitosan, with high degree of substitution, demonstrated excellent solubility in common organic solvents. Comprehensive characterization was performed using elemental analysis, nuclear magnetic resonance (including two-dimensional NMR), gel permeation chromatography, infrared spectroscopy, X-ray diffraction, and thermal analysis. The resulting films exhibited high water contact angles. Notably, as the fluorocarbon chain length increased, tensile strength gradually decreased, while elongation at break improved. Additionally, water uptake, water vapor transmission rate, and oxygen transmission rate all exhibited a declining trend. The films exhibited good biocompatibility, and in the grape preservation experiment, HFBC treatment effectively delayed grape aging and deterioration while enhancing quality preservation. These results suggest that HFBC film holds promising potential for food packaging applications.

Diabetic patients often struggle with wound healing and are at higher risk of infections, necessitating the development of a stretchable, adhesive hydrogel dressing with antibacterial and angiogenesis-promoting properties. In this study, we synthesized a series of adhesive, antibacterial and anti-inflammatory hydrogels using free radical polymerization with materials including methacrylated hyaluronic acid (HAMA), N-[tris(hydroxymethyl)methyl]acrylamide (THMA), and 3-(bis(pyridin-2-ylmethyl)amino)propyl methacrylate (DPAMA). By leveraging the strong affinity of zinc(II)-dipicolylamine coordination complexes for the phosphorylated groups in dexamethasone sodium phosphate (DMSP), Zn2+ and DMSP were successfully incorporated into the hydrogel. The results demonstrated that the hydrogels possessed excellent adhesiveness and mechanical properties, enabling them to adhere closely to the skin while remaining easily removable without causing trauma. Antibacterial tests demonstrated significant inhibitory effects against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), attributed to the slow release of Zn2+, which effectively suppressed bacterial growth. Additionally, the slow release of DMSP provided strong anti-inflammatory effects. The DHTDZ2 hydrogel, containing 1.5 mg/mL Zn2+ and 4 mg/mL DMSP, significantly accelerated the healing of full-thickness skin wounds. In vitro angiogenesis, immunofluorescence, and immuno-histochemical results further confirmed that the DHTDZ2 hydrogel promoted angiogenesis and reduced the expression of pro-inflammatory factors. In summary, the hydrogel is an effective wound healing dressing that can reduce wound infections and inflammation.

Our previous study showed that as a substitute for statins, selenium-enriched kiwifruit (Se-Kiwi) might reduce blood lipids and protect the liver in Kunming mice, but the underlying mechanism remains unclear. Metabolic regulation of mammalian intestinal microflora plays an important role in obesity and related diseases induced by a high-fat diet (HFD). Here, samples of serum, liver, colon, and fresh feces from the Se-Kiwi-treated hyperlipidemia C57BL/6J mouse model were collected. Based on metabolome (UHPLC-Q-TOF MS) and gut microbiome (16S rDNA) analyses as well as the integrative analysis of physiological and biochemical indices and pathological data of mice, we aimed to systematically illustrate the gut microbiome and metabolomics mechanism of Se-Kiwi in HFD-induced hyperlipidemic mice. As a result, Se-Kiwi can significantly increase the abundance of potentially beneficial gut bacteria such as Parabacteroides, Bacteroides, and Allobaculum in the colon and improve hyperlipidemia by regulating the digestion and absorption of vitamins, pyrimidine metabolism, purine metabolism, and other metabolic pathways, which have been confirmed by the following fecal microbiota transplantation experiment. This process was significantly regulated by the Ada, Gda, Pank1, Ppara, Pparg, and Cd36 genes. These findings may provide a theoretical basis for the research and development of selenium-enriched functional foods in the treatment of hyperlipidemia.